Deloitte Recap LLC
Helping clients navigate the life sciences industry
Insight into Action
Deloitte Recap LLC is a market innovator and industry leading authority on the analysis of biopharma alliances, valuations, and analysis of clinical developments. Deloitte Recap provides consulting and advisory services backed by data-driven solutions using DEAL builder™ and VALUATION analyzer™ to help support decisions around alliance formations, alliance management, royalty determinations, and deal valuations and DEVELOPMENT optimizer™ to help support decisions around clinical development, regulatory performance, termination, and benchmarking.
The Recap IQ Series by Deloitte™ provides extensive biopharma alliance information, deal values, and drug development histories to support the development of alliance and clinical development programs.
Prepare for deal negotiations with leading practices on alliance formation, deal comparables, and critical deal terms.
Evaluate current alliance values and shape future deals with post-launch payment data and trends in effective royalty rates by stage at signing.
Make data-driven drug development decisions with highly curated data and decision support capabilities.
Alliance Advisory Services
- Alliance Structuring and Deal Valuation
- Alliance Maintenance and Assessment
- Business Development Services
- Litigation Preparation and Support
- Reasonable Royalty Assessment
- Transfer Pricing
Clinical Development Advisory Services
- Clinical Portfolio Management
- Avoiding Late-Stage Failures
- Regulatory and Clinical Success
Webinar Series. Deloitte Recap hosts a series of webinars that are presented live online. To register for an upcoming event or access archived presentations, visit www.recap.com/webinar.
Quarterly Reviews. Quarterly reports from the Deloitte Recap analysts offering insights into industry developments. Read the latest reviews and sign up to receive new editions at www.recap.com/review.
White Papers. White papers written by Deloitte Recap analysts using Deloitte Recap data. Deloitte Recap’s most recent white paper is Innovative Strategies for Oncology Drug Development. This white paper analyzes 29 successfully licensed cancer therapeutics developed by leading biopharmaceutical companies to examine how they have won a growing share of oncology drug approvals. Visit www.recap.com/whitepaper to register for a complimentary copy.
Allicense Conference (pronounced “ah-lie-sense”) is a must-attend event for hundreds of Biotech and Pharmaceutical business development and finance executives each year. The conference provides an opportunity to hear the industry’s leaders discuss the latest trends and leading practices affecting our industry.
May 3 & 4, 2011
The Westin St. Francis on Union Square, San Francisco, CA
For more details, visit www.recap.com/allicense.
Stay Connected: Subscriptions
Recap IQ Series by Deloitte, DEAL builder, VALUATION analyzer, and DEVELOPMENT optimizer are trademarks of Deloitte Recap LLC. As used in this document, ‘Deloitte’ means Deloitte LLP (and its subsidiaries). Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.